menu
    • menu

    Company profile for Immix Biopharma

    NEW Drugs in Dev: 5
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Immix Biopharma's mission is to develop novel and game-changing cancer therapies. Immix is dedicated to the memory of Donald E. Senn, Ph.D. who tragically lost his life to cancer at the height of a vibrant career as a biomedical scientist, and to all of the cancer patients around the world who continue their brave fight. Immix was created to leverage the latest developments in the fields of nanotechnology and drug delivery for...
    Immix Biopharma's mission is to develop novel and game-changing cancer therapies. Immix is dedicated to the memory of Donald E. Senn, Ph.D. who tragically lost his life to cancer at the height of a vibrant career as a biomedical scientist, and to all of the cancer patients around the world who continue their brave fight. Immix was created to leverage the latest developments in the fields of nanotechnology and drug delivery for the creation of novel and effective cancer therapeutics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Immix BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11150 West Olympic Blvd Los Angeles, CA 90064
    Telephone
    Telephone
    +1 (888) 958-1084
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.immixbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/immix-biopharma
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immix Bio Gets FDA Breakthrough Designation For NXC-201
    Immix Bio Gets FDA Breakthrough Designation For NXC-201

    28 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/28/3227633/0/en/Immix-Biopharma-Receives-U-S-FDA-Breakthrough-Therapy-Designation-for-NXC-201.html

    GLOBENEWSWIRE
    28 Jan 2026
    Share Share
    Immix Biopharma Closes Upsized $100M Underwritten Common Offering
    Immix Biopharma Closes Upsized $100M Underwritten Common Offering

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202839/0/en/Immix-Biopharma-Announces-Closing-of-Upsized-100-Million-Underwritten-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    Immix Biopharma Reports Positive Phase 2 NXC-201 Data at ASH 2025
    Immix Biopharma Reports Positive Phase 2 NXC-201 Data at ASH 2025

    07 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/07/3201155/0/en/At-ASH-2025-Oral-Presentation-Immix-Biopharma-Reports-Positive-Phase-2-NXC-201-Results-Advancing-Toward-BLA-Submission-as-a-Potentially-First-and-Best-in-Class-Therapy-for-relapsed.html

    GLOBENEWSWIRE
    07 Dec 2025
    Share Share
    Immix Bio Sets $100M Stock Offering With Pre-Funded Warrants
    Immix Bio Sets $100M Stock Offering With Pre-Funded Warrants

    07 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/07/3201157/0/en/Immix-Biopharma-Announces-Pricing-of-Upsized-100-Million-Underwritten-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html

    GLOBENEWSWIRE
    07 Dec 2025
    Share Share
    Immix Bio Appoints Chief Commercial Officer For NXC-201 Launch
    Immix Bio Appoints Chief Commercial Officer For NXC-201 Launch

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186298/0/en/Immix-Biopharma-Appoints-Chief-Commercial-Officer-to-Drive-NXC-201-Launch.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Immix Bio's NXC-201 Shows Positive Results at ASH 2025
    Immix Bio's NXC-201 Shows Positive Results at ASH 2025

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179312/0/en/Immix-Biopharma-s-NXC-201-NEXICART-2-Clinical-Trial-Results-Selected-for-Oral-Presentation-at-ASH-2025.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search